On September 6, 2024, Strides Pharma Science Limited announced that its subsidiary, Strides Pharma Global Pte. Limited in Singapore has received approval from the USFDA for its generic version of Theophylline Extended-Release Tablets in 300 mg and 450 mg dosages. These tablets are similar in effect to the brand name drug THEO-DUR® by Schering Corp. …